Regulus Therapeutics Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Regulus Therapeutics Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Regulus Therapeutics Inc. Operating Lease, Payments for the quarter ending December 31, 2019 was $105K.
  • Regulus Therapeutics Inc. Operating Lease, Payments for the twelve months ending December 31, 2019 was $756K.
  • Regulus Therapeutics Inc. annual Operating Lease, Payments for 2023 was $776K, a 2.92% increase from 2022.
  • Regulus Therapeutics Inc. annual Operating Lease, Payments for 2022 was $754K, a 61.1% increase from 2021.
  • Regulus Therapeutics Inc. annual Operating Lease, Payments for 2021 was $468K, a 9.09% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $776K +$22K +2.92% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $754K +$286K +61.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $468K +$39K +9.09% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $429K -$327K -43.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $756K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.